Europe Prefilled Syringes Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Nov 2019
  • Europe
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Europe Prefilled Syringes Market By Material (Glass Prefilled Syringes, Polymer Based Prefilled Syringes, Plastic Prefilled Syringes), Design (Single-Chamber Prefilled Syringes, Customized Prefilled Syringes, Dual-Chamber Prefilled Syringes), Type (Conventional Prefilled Syringe, Safety Prefilled Syringes) Therapeutics (Large Molecules, Small Molecules), Application (Monoclonal Antibodies, Rheumatoid Arthritis, Anaphylaxis, Cancer, Diabetes, Multiple Sclerosis, Vaccines and Others), Distribution Channel (Hospitals, Mail Order Pharmacies, Ambulatory Surgery Centers), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe) - Industry Trends and Forecast to 2026

Market Analysis: Europe Prefilled Syringes Market

Europe prefilled syringes market is registering a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to home market growth in healthcare and benefits of using traditional prefilled syringes.

Market Definition: Europe Prefilled Syringes Market

A pre-filled syringe is a disposable syringe that is supplied with the substance to be injected. These are new devices used to distribute drugs that are more reliable, cost-effective, secure, comfortable, sterile, safe and affordable. Over the duration of 2017, an estimated 72,000 drug overdose fatalities have been recorded to mark a rise of about 10% in 2017, nearly half of which could have been avoided by the use of pre-filled syringes in healthcare procedures according to the Center for Disease Control.

Market Drivers

  • Home market growth in healthcare is driving the growth of the market
  • Increased use of injectable medicines is propelling the growth of the market
  • Enhanced chronic disease occurrence is boosting the growth of the market
  • Benefits of using traditional prefilled syringes is contributing to the growth of the market

Market Restraints

  • Strong federal rules is hampering the growth of the market
  • Different drug delivery methods are available which is hindering the growth of the market
  • Remembrance of material is restricting the growth of the market

Segmentation: Europe Prefilled Syringes Market

By Material

  • Glass prefilled syringes

  • Polymer based prefilled syringes
  • Plastic prefilled syringes

By Design

  • Single-chamber prefilled syringes
  • Customized prefilled syringes
  • Dual-chamber prefilled syringes

By Type

  • Conventional prefilled syringe
  • Safety prefilled syringes

By Therapeutics

  • Large Molecules
  • Small Molecules

By Application

  • Monoclonal antibodies
  • Rheumatoid arthritis
  • Anaphylaxis
  • Cancer
  • Diabetes
  • Multiple sclerosis
  • Vaccines
  • others

By Distribution Channel

  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers

By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe

Key Developments in the Market:

  • In May 2019, Fresenius Kabi AG, maker of the EU-authorized biosimilar adalimumab, Idacio, has introduced its drug in Germany. Fresenius Kabi also made the biosimilar eligible for purchase in pre-filled syringes, pre-filled pens and vial presentations. Data source included pharmacokinetic, biosimilar and immunogenic safety trials in healthy volunteers and phase 3 moderate and extreme Psoriasis clinicians of up to 52 weeks of reported results. The company received authorization from the European Commission to sell the drug. The company has expanded its product portfolio and increased its market share with this approval.
  • In December 2018, Terumo Corporation announced the launch of a biosimilar, which utilizes the company's PLAJEX pre-filled syringe, in Europe. Terumo manufactures the drug Hulio, a biosimilar to Humira (adalimumab). The first international trade launches represents an important milestone of PLAJEX. The formulation of Hulio was designed jointly by Fujifilm Kyowa Kirin Biologics Co., Ltd. and Terumo. The manufacturing process is carried out by the Terumo Yamaguchi D&D Corporation, a wholly-owned subsidiary of Terumo Corporation, and Mylan N.V. The launch increased the company's product range and its market share.

Competitive Analysis:

Europe prefilled syringes market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prefilled syringes market for Europe.

Key Market Competitors:

Few of the major market competitors currently working in the Europe prefilled syringes market are BD, Stevanato Group, WIPO, Vetter Pharma,, CHEMI S.p.A., NIPRO, Daetwyler Holding, Bayer AG, SCHOTT AG, Gerresheimer AG, Haselmeier, Catalent, Inc, Baxter, Medtronic, West Pharmaceutical Services, Inc.,Terumo Corporation among others.

Research Methodology:  Europe Prefilled Syringes Market

 Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Europe prefilled syringes market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE